Policy question : Should vaccination with the Janssen COVID-19 vaccine (1-dose, IM) be recommended for persons 18 years of age and older under an emergency use authorization?

Details

• Corporate Authors:
  United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
• Description:
  05-COVID-Oliver.pdf
• Subjects:
  Coronavirus Infections/prevention & Control COVID-19 Vaccines Pandemics Vaccination Viral Vaccines
• Series:
  ACIP: Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Still Image
• Name as Subject:
  ACIP meeting: 2021 Feb-Mar ; Janssen COVID-19 Vaccine ; Coronavirus Infections/prevention & control ; COVID-19 Vaccines ; Pandemics ; Vaccination ; Viral Vaccines ; ACIP meeting: 2021 Feb-Mar ; Janssen COVID-19 Vaccine ; Coronavirus Infections/prevention & control ; COVID-19 Vaccines ; Pandemics ; Vaccination ; Viral Vaccines
• Genre:
  Presentation ; Conference Publications
• Volume:
  202103
• Issue:
  0100105
• Collection(s):
  Advisory Committee on Immunization Practices (ACIP)
• Main Document Checksum:
  urn:sha-512:ee9e3dd930f345b0baaa44d28be85a4c76e14992519bfe6985d0b45e9de07f3724657de455a2f3ca5008a3ad2c27cae24a68a837b4b9ab232825af0e795c866d
• Download URL:
  https://stacks.cdc.gov/view/cdc/105731/cdc_105731_DS1.pdf
• File Type:
  [PDF - 185.34 KB ]